Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Zengyu Feng^#^{1

2}, Kexian Li^#¹, Kai Qin^#¹, Juyong Liang^#^{3

4}, Minmin Shi¹, Yang Ma¹, Shiwei Zhao¹, Huaiyu Liang⁵, Dongni Han⁶, Baiyong Shen^{1

7

8}, Chenghong Peng^{9

10}, Hao Chen^{11

12}, Lingxi Jiang^{13

14}

Affiliations

¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
² Department of General Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
³ Otolaryngology and Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People'S Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, People's Republic of China.
⁴ Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
⁵ Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
⁶ State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, People's Republic of China.
⁷ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China.
⁸ Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
⁹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. chhpeng@yeah.net.
¹⁰ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. chhpeng@yeah.net.
¹¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. haochendr@126.com.
¹² Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. haochendr@126.com.
¹³ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. jlx12120@rjh.com.cn.
¹⁴ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. jlx12120@rjh.com.cn.

^# Contributed equally.

PMID: 37908024
PMCID: PMC10619305
DOI: 10.1186/s13045-023-01506-5

Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Zengyu Feng et al. J Hematol Oncol. 2023.

. 2023 Nov 1;16(1):109.

doi: 10.1186/s13045-023-01506-5.

Authors

Affiliations

¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China.
² Department of General Surgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, People's Republic of China.
³ Otolaryngology and Head and Neck Center, Cancer Center, Department of Head and Neck Surgery, Zhejiang Provincial People'S Hospital (Affiliated People's Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, People's Republic of China.
⁴ Key Laboratory of Endocrine Gland Diseases of Zhejiang Province, Hangzhou, Zhejiang, People's Republic of China.
⁵ Department of Pathology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, People's Republic of China.
⁶ State Key Laboratory of Analytical Chemistry for Life Science, School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, People's Republic of China.
⁷ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China.
⁸ Institute of Translational Medicine, Shanghai Jiao Tong University, Shanghai, People's Republic of China.
⁹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. chhpeng@yeah.net.
¹⁰ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. chhpeng@yeah.net.
¹¹ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. haochendr@126.com.
¹² Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. haochendr@126.com.
¹³ Department of General Surgery, Pancreatic Disease Center, Research Institute of Pancreatic Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, People's Republic of China. jlx12120@rjh.com.cn.
¹⁴ Shanghai Key Laboratory of Translational Research for Pancreatic Neoplasms, Shanghai, People's Republic of China. jlx12120@rjh.com.cn.

^# Contributed equally.

PMID: 37908024
PMCID: PMC10619305
DOI: 10.1186/s13045-023-01506-5

No abstract available

PubMed Disclaimer

Retraction of

The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Feng Z, Li K, Qin K, Liang J, Shi M, Ma Y, Zhao S, Liang H, Han D, Shen B, Peng C, Chen H, Jiang L. Feng Z, et al. J Hematol Oncol. 2022 Aug 17;15(1):112. doi: 10.1186/s13045-022-01338-9. J Hematol Oncol. 2022. Retraction in: J Hematol Oncol. 2023 Nov 1;16(1):109. doi: 10.1186/s13045-023-01506-5. PMID: 35978332 Free PMC article. Retracted.

Publication types

Actions

LinkOut - more resources

Full Text Sources
- PubMed Central

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Affiliations

Retraction Note: The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA

Authors

Affiliations

Retraction of

Publication types

LinkOut - more resources

Full Text Sources